Hart Elvin't, Odé Zelda, Derieppe Marc P P, Groenink Lucianne, Heymans Martijn W, Otten René, Lequin Maarten H, Janssens Geert O R, Hoving Eelco W, van Vuurden Dannis G
Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands.
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The UMC Utrecht Brain Center, Utrecht, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Clin Transl Radiat Oncol. 2022 May 4;35:44-55. doi: 10.1016/j.ctro.2022.04.013. eCollection 2022 Jul.
Radiotherapy (RT) is a cornerstone treatment strategy for brain tumours. Besides cytotoxicity, RT can cause disruption of the blood-brain barrier (BBB), resulting in an increased permeability into the surrounding brain parenchyma. Although this effect is generally acknowledged, it remains unclear how and to what extent different radiation schemes affect BBB integrity. The aim of this systematic review and meta-analysis is to investigate the effect of photon RT regimens on BBB permeability, including its reversibility, in clinical and preclinical studies. We systematically reviewed relevant clinical and preclinical literature in PubMed, Embase, and Cochrane search engines. A total of 69 included studies (20 clinical, 49 preclinical) were qualitatively and quantitatively analysed by meta-analysis and evaluated on key determinants of RT-induced BBB permeability in different disease types and RT protocols. Qualitative data synthesis showed that 35% of the included clinical studies reported BBB disruption following RT, whereas 30% were inconclusive. Interestingly, no compelling differences were observed between studies with different calculated biological effective doses based on the fractionation schemes and cumulative doses; however, increased BBB disruption was noted during patient follow-up after treatment. Qualitative analysis of preclinical studies showed RT BBB disruption in 78% of the included studies, which was significantly confirmed by meta-analysis (p < 0.01). Of note, a high risk of bias, publication bias and a high heterogeneity across the studies was observed. This systematic review and meta-analysis sheds light on the impact of RT protocols on BBB integrity and opens the discussion for integrating this factor in the decision-making process of future RT, with better study of its occurrence and influence on concomitant or adjuvant therapies.
放射治疗(RT)是脑肿瘤的一种基石性治疗策略。除了细胞毒性外,放疗还会导致血脑屏障(BBB)破坏,致使周围脑实质的通透性增加。尽管这种效应已得到普遍认可,但不同放疗方案如何以及在何种程度上影响血脑屏障的完整性仍不清楚。本系统评价和荟萃分析的目的是在临床和临床前研究中,探讨光子放疗方案对血脑屏障通透性的影响,包括其可逆性。我们在PubMed、Embase和Cochrane搜索引擎中系统检索了相关的临床和临床前文献。通过荟萃分析对总共69项纳入研究(20项临床研究、49项临床前研究)进行了定性和定量分析,并根据不同疾病类型和放疗方案中放疗诱导的血脑屏障通透性的关键决定因素进行了评估。定性数据综合分析显示,35%的纳入临床研究报告放疗后血脑屏障破坏,而30%的研究结果不明确。有趣的是,基于分割方案和累积剂量计算的不同生物学有效剂量的研究之间未观察到明显差异;然而,在治疗后的患者随访期间,血脑屏障破坏有所增加。临床前研究的定性分析显示,78%的纳入研究存在放疗引起的血脑屏障破坏,荟萃分析显著证实了这一点(p<0.01)。值得注意的是,观察到研究存在高偏倚风险、发表偏倚以及高度异质性。本系统评价和荟萃分析揭示了放疗方案对血脑屏障完整性的影响,并开启了将该因素纳入未来放疗决策过程的讨论,同时更好地研究其发生情况及其对同步或辅助治疗的影响。